Genky DrugStores Co., Ltd. (9267.T)
JPY 3190.0
(1.11%)
JPY 3190.0
(1.11%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 6.32 Billion JPY | 32.75% |
| 2022 | 4.76 Billion JPY | 7.78% |
| 2021 | 4.42 Billion JPY | -8.52% |
| 2020 | 4.83 Billion JPY | 75.38% |
| 2019 | 2.75 Billion JPY | 2.13% |
| 2018 | 2.69 Billion JPY | -13.49% |
| 2017 | 3.11 Billion JPY | 9.58% |
| 2016 | 2.84 Billion JPY | 49.67% |
| 2015 | 1.9 Billion JPY | 7.95% |
| 2014 | 1.76 Billion JPY | 50.4% |
| 2013 | 1.17 Billion JPY | 87.96% |
| 2012 | 623.06 Million JPY | -45.55% |
| 2011 | 1.14 Billion JPY | 26.54% |
| 2010 | 904.22 Million JPY | 37.82% |
| 2009 | 656.09 Million JPY | 36.63% |
| 2008 | 480.2 Million JPY | -46.69% |
| 2007 | 900.72 Million JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 1.58 Billion JPY | -15.2% |
| 2023 Q3 | 1.36 Billion JPY | -16.68% |
| 2023 FY | 6.32 Billion JPY | 32.75% |
| 2023 Q2 | 1.64 Billion JPY | 13.78% |
| 2023 Q1 | 1.44 Billion JPY | -0.48% |
| 2023 Q4 | 1.86 Billion JPY | 36.45% |
| 2022 Q2 | 1.16 Billion JPY | 6.08% |
| 2022 Q3 | 1.04 Billion JPY | -10.86% |
| 2022 Q4 | 1.45 Billion JPY | 39.25% |
| 2022 Q1 | 1.1 Billion JPY | -18.68% |
| 2022 FY | 4.76 Billion JPY | 7.78% |
| 2021 Q3 | 933.21 Million JPY | 3.68% |
| 2021 FY | 4.42 Billion JPY | -8.52% |
| 2021 Q1 | 1.23 Billion JPY | -13.16% |
| 2021 Q2 | 900.13 Million JPY | -26.95% |
| 2021 Q4 | 1.35 Billion JPY | 45.21% |
| 2020 Q4 | 1.41 Billion JPY | 45.35% |
| 2020 Q3 | 976.22 Million JPY | -14.99% |
| 2020 Q2 | 1.14 Billion JPY | -10.84% |
| 2020 Q1 | 1.28 Billion JPY | 24.3% |
| 2020 FY | 4.83 Billion JPY | 75.38% |
| 2019 Q2 | 257.57 Million JPY | -46.21% |
| 2019 Q4 | 1.03 Billion JPY | 5.49% |
| 2019 FY | 2.75 Billion JPY | 2.13% |
| 2019 Q1 | 478.81 Million JPY | -12.88% |
| 2019 Q3 | 982.34 Million JPY | 281.38% |
| 2018 Q3 | 672.28 Million JPY | 5.92% |
| 2018 Q4 | 549.58 Million JPY | -18.25% |
| 2018 FY | 2.69 Billion JPY | -13.49% |
| 2018 Q1 | 841.01 Million JPY | -25.41% |
| 2018 Q2 | 634.68 Million JPY | -24.53% |
| 2017 Q1 | 781.69 Million JPY | -20.46% |
| 2017 Q4 | 1.12 Billion JPY | 95.54% |
| 2017 Q3 | 576.62 Million JPY | -8.83% |
| 2017 FY | 3.11 Billion JPY | 9.58% |
| 2017 Q2 | 632.47 Million JPY | -19.09% |
| 2016 Q4 | 982.73 Million JPY | 103.2% |
| 2016 Q1 | 759.2 Million JPY | 2.57% |
| 2016 Q2 | 620.17 Million JPY | -18.31% |
| 2016 Q3 | 483.62 Million JPY | -22.02% |
| 2016 FY | 2.84 Billion JPY | 49.67% |
| 2015 FY | 1.9 Billion JPY | 7.95% |
| 2015 Q4 | 740.19 Million JPY | 115.89% |
| 2015 Q3 | 342.85 Million JPY | -9.95% |
| 2015 Q2 | 380.72 Million JPY | -12.99% |
| 2015 Q1 | 437.57 Million JPY | -9.18% |
| 2014 Q4 | 481.82 Million JPY | 9.6% |
| 2014 FY | 1.76 Billion JPY | 50.4% |
| 2014 Q1 | 455.78 Million JPY | -15.57% |
| 2014 Q2 | 384.09 Million JPY | -15.73% |
| 2014 Q3 | 439.63 Million JPY | 14.46% |
| 2013 FY | 1.17 Billion JPY | 87.96% |
| 2013 Q2 | 201.77 Million JPY | 15.82% |
| 2013 Q3 | 255.34 Million JPY | 26.55% |
| 2013 Q4 | 539.81 Million JPY | 111.41% |
| 2013 Q1 | 174.2 Million JPY | -44.28% |
| 2012 FY | 623.06 Million JPY | -45.55% |
| 2012 Q2 | 62.16 Million JPY | -62.97% |
| 2012 Q4 | 312.66 Million JPY | 288.96% |
| 2012 Q1 | 167.85 Million JPY | -55.57% |
| 2012 Q3 | 80.38 Million JPY | 29.32% |
| 2011 Q4 | 377.78 Million JPY | 39.25% |
| 2011 Q3 | 271.3 Million JPY | 14.16% |
| 2011 Q2 | 237.65 Million JPY | -7.69% |
| 2011 Q1 | 257.44 Million JPY | 0.37% |
| 2011 FY | 1.14 Billion JPY | 26.54% |
| 2010 Q2 | 140.43 Million JPY | -30.76% |
| 2010 Q3 | 304.45 Million JPY | 116.79% |
| 2010 FY | 904.22 Million JPY | 37.82% |
| 2010 Q1 | 202.84 Million JPY | 15.21% |
| 2010 Q4 | 256.49 Million JPY | -15.75% |
| 2009 Q2 | 124.26 Million JPY | -48.17% |
| 2009 FY | 656.09 Million JPY | 36.63% |
| 2009 Q4 | 176.06 Million JPY | 51.75% |
| 2009 Q1 | 239.74 Million JPY | 54.9% |
| 2009 Q3 | 116.02 Million JPY | -6.64% |
| 2008 Q3 | 151.33 Million JPY | 20.87% |
| 2008 Q2 | 125.2 Million JPY | 156.05% |
| 2008 Q1 | 48.89 Million JPY | 0.0% |
| 2008 FY | 480.2 Million JPY | -46.69% |
| 2008 Q4 | 154.77 Million JPY | 2.27% |
| 2007 FY | 900.72 Million JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| HEARTSEED INC | -1.47 Billion JPY | 529.182% |
| Cawachi Limited | 4.71 Billion JPY | -34.182% |
| Pharmarise Holdings Corporation | -351 Million JPY | 1901.709% |
| Qol Holdings Co., Ltd. | 4.88 Billion JPY | -29.59% |
| MatsukiyoCocokara & Co. | 52.34 Billion JPY | 87.919% |
| Welcia Holdings Co., Ltd. | 26.45 Billion JPY | 76.092% |
| Create SD Holdings Co., Ltd. | 13.69 Billion JPY | 53.809% |
| NIHON CHOUZAI Co.,Ltd. | 2.55 Billion JPY | -147.709% |
| COSMOS Pharmaceutical Corporation | 24.45 Billion JPY | 74.139% |
| Tsuruha Holdings Inc. | 24.1 Billion JPY | 73.765% |
| Ohki Healthcare Holdings Co.,Ltd. | 2.21 Billion JPY | -186.154% |
| Satudora Holdings Co.,Ltd. | 470 Million JPY | -1245.532% |
| Kusuri No Aoki Holdings Co., Ltd. | 12.3 Billion JPY | 48.615% |
| Medical System Network Co., Ltd. | 1.86 Billion JPY | -240.0% |
| Shinnihonseiyaku Co., Ltd. | 2.39 Billion JPY | -164.16% |
| Sugi Holdings Co.,Ltd. | 21.97 Billion JPY | 71.227% |
| YAKUODO HOLDINGS Co., Ltd. | 3.82 Billion JPY | -65.333% |
| Astena Holdings Co., Ltd. | 1.16 Billion JPY | -443.886% |
| Ain Holdings Inc. | 11.4 Billion JPY | 44.531% |
| Sundrug Co.,Ltd. | 29.12 Billion JPY | 78.287% |